HGCSG 1301: A Multicenter, Double-Blind, Randomized control phase II trial comparing Hange-shashin-to versus placebo to prevent diarrhea in patients with metastatic colorectal cancer under IRIS/Bev second-line treatment

Authors :: Satoshi Yuki
Kazunori Eto
Hiroshi Nakatsumi
Yasuo Komatsu
M. Tateyama
Yoshimitsu Kobayashi
Masayoshi Dazai
Takuto Miyagishima
Atsushi Sato
Koshi Fujikawa
Y. Sakata
Kazuteru Hatanaka
Hiroyuki Okuda
Masataka Yagisawa
Tetsuhito Muranaka
T. Saiki
Toraji Amano
Yasuyuki Kawamoto
Atsushi Ishiguro
S. Muto
Takenori Takahata
Masafumi Nakamura
Source :: Annals of Oncology. 29:v63
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: medicine.medical_specialty
Second line treatment
Colorectal cancer
business.industry
Hematology
Placebo
medicine.disease
Gastroenterology
Double blind
Diarrhea
medicine.anatomical_structure
Oncology
Internal medicine
medicine
In patient
Iris (anatomy)
medicine.symptom
business

Full Text Access

Tools